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Background: Particulate matter (PM) adverse effects on health include lung and heart damage. The
renin-angiotensin-aldosterone (RAAS) and kallikrein-kinin (KKS) endocrine systems are involved in the
pathophysiology of cardiovascular diseases and have been found to impact lung diseases. The aim of the
present study was to evaluate whether PM exposure regulates elements of RAAS and KKS.
Methods: Sprague–Dawley rats were acutely (3 days) and subchronically (8 weeks) exposed to coarse (CP),
fine (FP) or ultrafine (UFP) particulates using a particulate concentrator, and a control group exposed to filtered
air (FA). We evaluated the mRNA of the RAAS components At1, At2r and Ace, and of the KKS components B1r, B2r
and Klk-1 by RT-PCR in the lungs and heart. The ACE and AT1R protein were evaluated by Western blot, as were
HO-1 and γGCSc as indicators of the antioxidant response and IL-6 levels as an inflammation marker.
We performed a binding assay to determinate AT1R density in the lung, also the subcellular AT1R distribution in
the lungs was evaluated. Finally, we performed a histological analysis of intramyocardial coronary arteries and the
expression of markers of heart gene reprogramming (Acta1 and Col3a1).
Results: The PM fractions induced the expression of RAAS and KKS elements in the lungs and heart in a time-dependent
manner. CP exposure induced Ace mRNA expression and regulated its protein in the lungs. Acute and subchronic exposure
to FP and UFP induced the expression of At1r in the lungs and heart. All PM fractions increased the AT1R protein
in a size-dependent manner in the lungs and heart after subchronic exposure. The AT1R lung protein showed a
time-dependent change in subcellular distribution. In addition, the presence of AT1R in the heart was accompanied
by a decrease in HO-1, which was concomitant with the induction of Acta1 and Col3a1 and the increment of IL-6.
Moreover, exposure to all PM fractions increased coronary artery wall thickness.
Conclusion: We demonstrate that exposure to PM induces the expression of RAAS and KKS elements, including
AT1R, which was the main target in the lungs and the heart.
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Air quality has been associated with increases in the mor-
bidity and mortality due not only to pulmonary diseases but
also to cardiovascular diseases. While the first group of dis-
eases can be explained by the fact that the respiratory sys-
tem is the major route of exposure to air pollutants, the
second group could be a consequence of intermediate steps
that connect lung damage to cardiovascular alterations . Epi-
demiological studies indicate that particulate matter (PM) is
involved in these diseases and that exposure to particulate
less than 2.5 μm is a major risk factor for the promotion
and exacerbation of pulmonary and heart diseases [1–4].
The main mechanisms proposed to explain PM-induced
toxic effects on human health are inflammation and oxi-
dative stress. Recently, it has been demonstrated that the
inflammatory response to PM promotes accelerated clot-
ting with the participation of IL-6 cytokine [5]. Further-
more, oxidative stress can decrease heart rate variability
after acute PM exposure [6]. Both mechanisms are in-
volved in the pathophysiology of lung and heart diseases,
i.e., COPD, asthma, fibrosis, hypertension, atherosclerosis,
thrombosis, heart failure, etc., and are able to regulate or
promote physiological responses including the activation
of macrophages and neutrophils, regulation of the vascu-
lar tone, and production of mediators of signaling path-
ways, amongst others.
Important endocrine systems that regulate cardiovas-
cular physiology are the Renin-Angiotensin-Aldosterone
system (RAAS) and the Kallikrein-Kinin system (KKS).
Both systems are composed of peptidase enzymes [angio-
tensin-I converting enzyme type-1 and -2 (ACE and ACE2,
respectively) and tissue kallikrein (KLK-1)]; and receptors
[angiotensin receptors type-1 and type-2 (AT1R and AT2R,
respectively); and bradykinin receptors type-1 and type-2
(B1R and B2R)]; and peptide precursors [angiotensinogen
and kininogen (ANG and KNG, respectively)] [7–10]. Both
systems control cardiac muscle contraction through vaso-
active peptides, RAAS induces vasoconstriction through
the ACE/Ang-II/AT1R axis, but by itself, RAAS can induce
vasodilatation by the stimulation of NO-bradykinin
dependent release through ACE2/Ang-(1-7)/Mas receptor
axis [11], which also, in cooperation with B2R, AT2R in-
duces a vasodilatation effect. This effect orchestrated by
B2R, increases the release of NO through the activation of
endothelial oxide nitric synthase (eNOS) [8, 12]. Vascular
dilatation has been reported to be dependent of KLK-1,
B2R and AT2R [13], where KLK-1 has an important role in
the generation of the vasodilator peptides (bradykinin and
kallidin) [14, 15].
Moreover, angiotensin-II through the AT1R promotes
the activation of NADH/NADPH oxidase and the produc-
tion of superoxide anion radicals as second messengers
[16, 17] as well as B1R receptor does when it recognizes
the des-Arg-bradykinin [18, 19]. In this sense, AT1Ractivation induces the expression of B1R [20, 21] and both
induce a vasoconstriction effect with an increment in
blood pressure [19, 22].
Furthermore, during the inflammation process RAAS
and KKS are active participants of this process, AT1R is up-
regulated by TNFα [23], IL-6 [24] and IL-1α, but is down-
regulated by TNFα and INFγ combined [25]. Ang-II,
through AT1R, induces IL-6 release and is inhibited by pyr-
rolidine dithiocarbamate radical scavenger [26]. On the
other hand there is not enough information about cyto-
kines regulating AT2R expression. KKS induces allodynia
through B1R as part of the role in hyperalgesia [18]; macro-
phages release TNFα and IL-1 through the B1R pathway
[27]. In lung fibroblasts B2R activation induces the release
of IL-6 and IL-8 [28], and also IL-1β through a NF-κB-
dependent pathway [28]. In summary, both systems control
cardiac muscle contraction, levels of nitric oxide [8, 29],
and are involved in the inflammatory response [30, 31] and
in the blood coagulation state [32, 33].
There is a sustained cross-talk and a counterbalance
between RAAS and KKS through the activation and
degradation of vasoactive peptides through angiotensin-
converting enzyme-I (ACE), which activates angiotensin-I
to angiotensin-II and degrades bradykinin to bradykinin
(1-5) [34–36]. It is important to note that one of the main
metabolic functions of the lungs is the activation and deg-
radation of these peptides [36, 37].
During pathological cardiovascular states, the RAAS is
overexpressed, as demonstrated in diseases such as hyper-
tension, atherosclerosis, heart infarction and heart failure.
However, recent evidence also indicates its participation
in the pulmonary fibrosis induced by bleomycin [38] and
bronchial hyperresponsiveness in asthmatic patients [39].
PM exposure has been established as a risk factor for
lung and cardiovascular diseases, and RAAS and KKS
are involved in the pathophysiology of these afflictions.
However, there is not currently enough evidence to
confirm whether RAAS and KKS are involved in the
response to PM exposure. Ulrich et al. demonstrated
that the activity of angiotensin-converting enzyme
(ACE) in plasma and its mRNA in the lung decreased
after 4 or 7 days of exposure to ECH-93 PM and ozone
[40]. Gunisson and Chen reported a 1.5-fold increase in
the differential expression of At1r in a lung microarray
of double-knockout mice (apoE -/- and LDLr-/-) exposed
subchronically to ultrafine particulates (6 h/day; 5 days/
week for 4 months) [41]. Li et al. observed ex-vivo vaso-
constriction of pulmonary artery rings exposed to PM
(1-100 μg/ml), the soluble fraction of the PM, and
metals including copper and vanadium. This observa-
tion was associated with an activation of MAPK signal-
ing. These effects were completely inhibited by losartan
and partially with captopril, a blocker of AT1R and an
inhibitor of ACE, respectively [42]. Other studies using
Table 1 Particulate matter effects on gene expression of
angiotensin and bradykinin systems in the lungs. Semi-quantitative
expression results of angiotensin-receptor type-2 (At2r), bradykinin
receptor type-1 (B1r) and type-2 (B2r), and kallikrein (Klk-1) enzyme
after acute and subchronic exposures
Acute exposure
Group FA CP FP UFP
Gene
At2r 1 1.3 1.85 1.32
(0.6-1.4) (0.61-2.17) (1.1-2.5) (0.5-1.9)
B1r 1 1.05 1.3 1.08
(0.9-1.1) (0.8-1.2) (1.01-2) (0.9-1.1)
B2r 1.1 1.1 2 1.4
(0.6-1.2) (0.9-1.77) (0.9-3.1) (1.4-1.7)
Klk-1 1 1.12 1.88 * 1.43 *
(0.94-1.1) (0.76-1.3) (1.4-2) (1.1-2.35)
Subchronic exposure
Group FA CP FP UFP
Gene
At2r 1 0.73 0.85 0.82
(0.8-1.15) (0.7-1.1) (0.5-1.1) (0.6-1.1)
B1r 1 0.95 1. 1
(0.9-1.2) (0.9- 1.03) (0.94-1.5) (0.93-1.1)
B2r 1 1.03 1.6 1
(0.9-1.2) (1-1.2) (1.15-4.2) (0.93-1.1)
Klk-1 1 0.84 1.78 0.92
(0.8-1.2) (0.8-1.1) (0.7-2.7) (0.9-1.4)
Acute exposure was defined as 5 h per day for 3 days
Subchronic exposure was defined as 5 h per day, 4 days per week, for 8 weeks
All results were corrected using glyceraldehyde 3-phosphate dehydrogenase





Data are showed as median and range
* Indicates significantly different from FA
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cardiac remodeling observed to be associated with a
switch to fetal reprogramming, the induction of fibrosis
and hypertrophic markers and the impairment of the
myocardial contraction [43, 44]. These processes have
been reported to be mediated by RAAS.
There is not currently sufficient evidence to establish
whether PM exposure could affect expression of RAAS
and KKS elements. We therefore hypothesized that PM
regulates expression of RAAS and KKS elements in the
lungs, and concurrently in the heart, and these changes
are accompanied by antioxidant/inflammation and myo-
cardial gene responses.
The aim of this work was to screen for changes in
some RAAS- and KKS-related elements during in vivo
acute and subchronic exposures to three main airborne
particle fractions (coarse, fine and ultrafine particulates)
and to examine: 1) whether the effect of PM on RAAS
and KKS elements expression is present in the lungs and
concomitantly in the heart, 2) if there is a relationship
between the exposures and antioxidant responses (heme
oxygenase-1 and gamma-glutamyl-cysteine ligase), and
3) tissue damage by histological evaluation and changes
in fetal gene reprogramming.
Results and discussions
mRNA levels of angiotensin and bradykinin system
related-genes in the lungs
To evaluate whether PM exposure affects the angioten-
sin and bradykinin systems as an initial response to the
toxic effect of the three PM fractions, we evaluated the
mRNA levels of three genes of each endocrine system.
We observed an increase in the Klk-1 mRNA in the
lungs of the groups acutely exposed to FP and UFP,
which was the only response of the bradykinin system
observed after either exposure. However, the B1r and
B2r mRNA levels showed a tendency to increase after
the acute exposure; in the subchronic exposure, we did
not observe any response of the bradykinin system genes
(Table 1).
Our results demonstrate that, in the lungs, the KKS
system responds only after an acute exposure, and the
main gene that responded to airborne particulate was
Klk-1. This is a serine protease enzyme that is necessary
to produce kinin peptides. On this basis, particulate less
than 2.5 μm could interfere with the activation of kinin
peptides, which are necessary to activate bradykinin re-
ceptors. Bradykinin receptors are involved in the regula-
tion of nitric oxide, the main vasodilator molecule, and
are implicated in inflammation and vascular tone regula-
tion. The expression of the bradykinin receptors in the
lungs was not significantly altered for any of the expo-
sures (regardless of particle type or duration of expos-
ure). This could have been because both receptors areconstitutively expressed in the lung tissue, although they
can be induced by some cytokines including IL-1 and
TNFα. PM exposure is characterized by the induction of
cytokine release [8], but we did not observe changes in
the expression of these receptors.
On the other hand, major and significant mRNA
changes were observed for the At1r and Ace angiotensin
system genes in the lungs. These are two of the most im-
portant genes in this system and are therapeutic targets in
conditions such as hypertension (Fig. 1). For both periods
of exposure, we found an increase in the levels of At1r
mRNA in the groups exposed to FP and UFP compared
with those exposed to FA (Fig. 1a and b). In contrast to
the effects observed with FP and UFP fractions, we ob-
served a decrease in At1r mRNA levels in the group
A B
C D
Fig. 1 Particulate matter induces lung AT1R and ACE mRNA in a size- and time-dependent manner. The animals were exposed to coarse (CP), fine
(CP) and ultrafine particulate (UFP). A control group was exposed to filtered air (FA). The semi-quantitative levels of Angiotensin Receptor Type-1
(At1r) and Angiotensin-I Converting Enzyme (Ace) mRNA after acute (3 days, 5 h/d) and subchronic (8 weeks, 5 h/d, 4 d/week) exposure are
shown. Scatter dot plot shows the value of the median. Below each graph representatives gels illustrating the expression levels of mRNA are
shown. * indicates significant differences among groups (n = 4 per group, p < 0.05)
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levels were not significantly different among any of the
types of particle and exposure time conditions as shown
in Table 1. Our results for the Ace mRNA levels showed a
significant increment following the acute exposures to FP
and UFP, but not for the subchronic exposures (Fig. 1c and
d). On the other hand, the group exposed subchronically to
CP responded with a large increase in the Ace mRNA rela-
tive to all other groups (Fig. 1d). It has been reported that
RAAS elements can be expressed constitutively within the
cells of various tissues and can have intracrine, paracrine
and endocrine effects in the organism [10]. Angiotensin-II
is the product of the enzymatic activity of ACE and is the
ligand for AT1R and AT2R. Lung tissue expresses these
three genes, which are important in the regulation of the
pulmonary circulation. As a result of the exposures, At1r
and Ace responded to PM, but At2r did not. This suggests
that PM exposure modulates the activation of angiotensin-I
and the deactivation of bradykinin by up-regulating Ace
and promoting At1r up-regulation However, the regulation
of At2r, which has been considered to have an antagonistic
effect on the At1r signaling pathway, was not affected.All of these results indicate that PM can regulate two of
the principal endocrine systems involved in the regulation of
the cardiovascular system at mRNA level. Our data also
showed that KKS responds acutely, and not subchronically.
On the other hand, the expression of the RAAS genes in-
creased at the end of both exposures, but the responses dif-
fered according to the type of particle and the specific genes
affected. The mRNA levels of both endocrine systems sug-
gest that KKS and RAAS genes are implicated in the physio-
logical response induced by PM, and these gene expression
changes may result in changes in the protein levels.
Protein levels of AT1R and ACE in the lungs
Following the screening of the expression of RAAS- and
KKS-associated genes, we investigated whether the pro-
tein levels of AT1R and ACE, which demonstrated the
most significant changes in the mRNA, were also altered.
In the lung total protein extracts, we observed a statisti-
cally significant reduction in the levels of the AT1R protein
after acute exposures to FP or UFP (Fig. 2a). However, after
the subchronic exposure, our results showed an increase in
the AT1R protein levels for all three particle fractions
A B
C D

















































Fig. 2 Particle matter exposure regulates AT1R and ACE protein in a particle size-dependent manner. Animals were exposed to coarse (CP), fine (FP) and
ultrafine particulate (UFP), or filtered air (FA). a) and b) The protein levels of Angiotensin Receptor Type-1 (AT1R) and c) and d) Angiotensin-I Converting
Enzyme (ACE), after acute (3 days, 5 h/day) and subchronic (8 weeks, 5 h/day, 4 days/week) exposure, respectively, are shown as arbitrary units (AU). Scatter
dot plot shows the value of the median. * indicates significant differences among groups (n= 4 per group, p< 0.05)
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protein levels after acute exposure to CP, while in the sub-
chronic exposures, an increase in ACE levels was observed.
However, for both acute and subchronic exposures to FP
and UFP the ACE protein levels were variable. Therefore,
although we observed a decrease in the protein levels, the
differences were not statistically significant (Fig. 2c and d).
Our results show that exposure to PM was able to induce
the ACE and AT1R proteins as well as mRNA. Differences
were observed with respect to the particle fractions and
the target proteins. Acute exposure to CP caused a down-
regulation of the ACE protein, without a change of the
AT1R protein levels. In contrast, the subchronic exposure to
CP induced an increase in ACE protein, which was accom-
panied by the up-regulation of AT1R. However, FP and UFP
did not affect the ACE protein levels. Instead, AT1R was the
main molecular target of the FP and UFP fractions. No
differences between the FP- and UFP-induced effects on the
AT1R protein levels were observed. This could be explained
either by the fact that UFP are contained within the FP frac-
tion, which precludes separation of their effects, or because
they can reach the same region in the lungs, they induce
similar responses.Our data suggest that PM can regulate AT1R and ACE
protein levels in the lungs in a time- and possibly a PM
size-dependent manner. It is important to highlight that
the CP, for which we did not expect a response, was able
to modulate both genes, while the FP and UFP fractions
only modulated AT1R. This evidence confirms that CP
can promote pulmonary events as well as the PM
smaller than 2.5 μm, and suggests a possible contribu-
tion to cardiovascular impairment as a consequence of
exposure to PM.
[3H]-Angiotensin-II binding to lung membranes
Similar to other G protein-coupled receptors, upon activa-
tion AT1Rs can be internalized from the cell membrane to
the cytoplasm and then can be either recycled or degraded.
Because the reduction in AT1R protein after the acute ex-
posure to FP and UFP did not match the mRNA levels, we
performed a binding assay with labeled Ang-II as an alter-
native method to confirm the protein levels. First, we ob-
tained a saturation curve to determine the receptor density
and the affinity for [3H]-Angiotensin-II in lung membranes
obtained from rats that were not used in the PM experi-
ments. These determinations (Fig. 3a) yielded a maximum
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Fig. 3 Acute exposure to PM modifies [3H]-Angiotensin-II binding to the lung tissue membranes. a) Saturation binding. Membranes, obtained from naïve
animals as described in Methods, were incubated with the indicated concentrations of [3H]-Angiotensin-II. Specific receptor binding was determined by
subtracting the binding in the presence of 100 μM telmisartan from the total binding. The points show the means from quadruplicate determinations
from a single experiment, which was repeated twice more with membranes obtained from different naïve animals. The line drawn is the best fit to a
hyperbola. Best-fit values for the equilibrium dissociation constant (Kd) and maximum binding (Bmax) are given in the text. b) Single-point determinations.
Membranes were obtained from animals exposed to coarse (CP), fine (FP) and ultrafine particulate (UFP) or from the filtered air control group (FA), and
then incubated with 10 nM [3H]-Angiotensin-II. Specific receptor binding was determined by subtracting the binding in the presence of 10 μM telmisartan.
Scatter dot plot shows the value of the median. * Indicates significant differences among groups (n= 4 per group, p< 0.05)
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iments) and an equilibrium dissociation constant (Kd) of
2.8 nM (pKd 17.2 ± 7.7).
In single-point determinations with a near saturating
concentration (10 nM) of [3H]-Angiotensin-II, a reduc-
tion in the specific binding was observed in lung mem-
branes from the animals exposed to FP and UFP. In
contrast, exposure to CP increased the specific [3H]-
Angiotensin-II binding (Fig. 3b).
The binding data thus showed the same pattern as the
total protein detected immunologically. On this basis,
we infer that the internalization and degradation of
AT1R in the acute exposure could be induced by differ-
ent mechanisms such as an over-activation, a target of
oxidative stress and/or allosteric regulation by divalent
cations, similar to observations of other GPCRs [45, 46].
AT1R levels in subcellular fractions of lung tissue
The conventional paradigm for GPCRs indicates that the
activated receptors are internalized from the plasma mem-
brane to the cytoplasm where they may be degraded or
recycled [47]. However, new evidence indicates that some
GPCRs can be localized in the nuclear envelope [48]. In
the case of AT1R, Lu et al. reported that after 15 min of
stimulation of neuronal cell cultures with Ang-II, AT1R
was sequestered to the nuclear membrane [49]. However,
Tadevosyan et al. [50] demonstrated that the presence of
angiotensin receptors (AT1R and AT2R) in the nuclear
membrane is most likely a result of intracellular synthesis
and trafficking, and not the result of post-endocytotic traf-
ficking in cardiomyocyte cultures. For these reasons, we
evaluated the distribution of AT1R protein between the nu-
clei and the rest of the cell in the lung tissue followingexposure to airborne PM in both exposure schemes (Fig. 4).
For the acute exposures, we observed an increase in AT1R
in the non-nuclear fraction in all exposed groups, while in
the nuclear fraction we observed a reduction in protein
levels (Fig. 4, upper panel). On the other hand, following
the subchronic exposures, we observed the opposite re-
sponse: under these conditions, we observed a decrease in
AT1R levels in the non-nuclear fraction and an increase in
this protein in the nuclear fraction (Fig. 4, lower panel).
On the basis of our findings with respect to the subcel-
lular distribution of AT1R in the lung tissue, we suggest
that this receptor may mediate processes that include cell
proliferation, survival, inflammatory responses, DNA syn-
thesis and transcription as has been demonstrated for
other GPCRs found in the nuclear envelope [48]. For ex-
ample, nuclear AT1R activation has been demonstrated
using isolated nuclei from fetal rat myocytes. Stimulation
of these nuclei with angiotensin-II induced transcription
as indicated by [α-32P] UTP incorporation, and this effect
was inhibited by pertussis toxin [50].
IL-6 cytokine protein levels in lung
Pleiotropic cytokine IL-6 is involved in the acute phase of
inflammation and accelerates coagulation induced by PM
exposure in vivo [5]. In addition, in endothelium cells, IL-6
induced the expression of AT1R [24]. We observed a statis-
tically significant increase in lung IL-6 protein from the
acute exposure to the three PM fractions (Fig. 5a); on the
other hand, in the subchronic exposure a down regulation
in the three PM groups below the levels observed in the FA
group was observed (Fig. 5b). Our results indicate the
induction of lung IL-6 as a marker of the acute phase
of the inflammation process. IL-6 could be involved in the
A B
Fig. 4 Particle matter modifies the AT1R subcellular distribution in lung tissue in a time-dependent manner. Representative gels of Angiotensin-II type-I
receptor (AT1R) detection in lung nuclear and non-nuclear fractions after acute (upper panel) and subchronic (lower panel) exposure to coarse particulate
(CP), fine particulate (FP), ultrafine particulate (UFP) or filtered air (AF). We used GAPDH and acetylated Histone-4 (H4ac) as cytosolic and nuclear quality control
targets, respectively, and actin was used as a general protein loading control. Representative blot of n= 4
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trast, in the subchronic exposure a lack of induction of lung
IL-6 protein was observed and AT1R expression was in-
creased. If a molecular communication process takes place
between IL-6 and AT1R it only happens acutely, but not
subchronically, yet this hypothesis needs to be confirmed.
Expression of angiotensin and bradykinin system genes
in the heart
The results obtained in the lungs suggest a contribution of
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Fig. 5 Acute, but not subchronic, exposure to particle matter increases IL-6 in lu
(UFP), or filtered air (FA). The protein interleukine-6 (IL-6) levels after a) acute (3 da
are shown as arbitrary units (AU). Scatter dot plot shows the value of the medianthe KKS in the endocrine pulmonary response to PM dam-
age. These heterogeneous responses of gene expression ob-
served in the lungs following the acute and subchronic
exposures to airborne particulate fractions could be con-
veyed from the lungs to the heart.
As expected, we observed a response in the mRNA levels
of bradykinin-related genes in the heart following the expos-
ure to PM. Similar to the observations in the lungs, in the
heart there was an increase in Klk-1 after the acute exposure
to FP that was sustained in the subchronic exposure. Add-
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ngs. Animals were exposed to coarse (CP), fine (FP) and ultrafine particulate
ys, 5 h/day) and b) subchronic exposure (8 weeks, 5 h/day, 4 days/week),
. * indicates significant differences among groups (n= 4 per group, p< 0.05)
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to detect B2r in the heart samples; no positive amplification
was observed in the heart samples from any of the exposure
schemes. This observation confirms that, as previously re-
ported, B2r is a receptor which has a null or low expression
in the heart ventricles of the adult male rat [51–53].
Our results for the expression of KKS genes show that
there is a differential response between the lungs and the
heart: the heart responded to the exposures to the three
particulate with the induction of B1r mRNA. These results
suggest that the inflammatory factors or chemical compo-
nents are released from the lungs and enter in the blood
stream of the pulmonary circulation before being translo-
cate to the heart. Although we observed this response to
all three particulate, FP, but not UFP, was able to induce
Klk-1, which indicates that there are differences betweenTable 2 Particulate matter effects on gene expression of
angiotensin and bradykinin systems in the heart. Semi-quantitative
expression results for angiotensin-receptor type-2 (At2r), Bradykinin
receptor type-1 (B1r) and kallikrein (Klk-1) enzyme after acute and
subchronic exposures
Acute exposure
Group FA CP FP UFP
Gene
At2r 1 1 1 1
(0.8-1.2) (1-1.1) (0.9-1.1) (0.5-1)
Ace 1 1.6 * 1.1 1.7 *
(0.9-1.1) (1.4-1.8) (0.9-1.3) (1.1-2.1)
B1r 1 1.7 * 2.2 * 1.9 *
(0.8-1.3) (1.4-2.2) (2.1-2.6) (1.3-2.4)
Klk-1 1 1.2 1.6 * 1.4 *
(0.8-1.2) (1-1.5) (1.4-1.9) (1.2-1.5)
Subchronic exposure
Group FA CP FP UFP
Gene
At2r 1 0.97 0.92 0.71 *
(0.96-1.03) (0.97-1.05) (0.72-0.9) (0.7-0.8)
Ace 1 1 1 0.9
(0.9-1.1) (0.9-1.1) (0.9-1.3) (0.8-1)
B1r Not determined
Klk-1 1 1.1 1.2 * 1.1
(0.9-1.1) (0.9-1.2) (1.19-1.22) (1-1.3)
Acute exposure was defined as 5 h per day for 3 days
Subchronic exposure was defined as 5 h per day, 4 days per week,
during 8 weeks






Data are showed as median and range
* Indicates significantly different from FAthese two particle fractions and suggests that FP could
affect the metabolism of kinin peptides.
With respect to the angiotensin system, the heart At2r
mRNA levels were not significantly different among the
acute exposure groups. In contrast, subchronic exposure
to UFP caused a significant decrease in the heart At2r
levels (Table 2). The Ace mRNA increased after acute
exposure to either CP or UFP, but these changes did not
persist in the subchronic exposure (Table 2). We ob-
served an increase in the At1r mRNA levels after acute
and subchronic exposure to FP, as well as in the group
after the subchronic exposure to UFP (Fig. 6).
The cardiac over-expression of AT1R has been demon-
strated to be involved with the promotion and exacerba-
tion of myocardial impairment. It is relevant to note that
short PM exposure was able to induce At1r, which was
maintained in the subchronic exposure. This observation
was accompanied with a down-regulation of At2r only
after the subchronic exposure, indicating that exposure to
PM, an environmental air pollutant, can increment the ex-
pression of At1r in the absence of counterbalancing
changes in the expression of At2r.
Up-regulation of Col3a1 and Acta1 in presence of AT1R
and IL-6 in the heart
Two of the main classes of response genes in the heart dur-
ing pathological states of cardiac damage are the heart fetal
reprogramming genes and the expression of genes involved
in the deposition of the extracellular matrix. We chose alpha
skeletal actin (Acta1) and collagen-III (Col3a1) as two repre-
sentative markers of myocardial adaptive response to dam-
age. We analyzed these genes in heart ventricular samples
after the acute exposures, and did not observe any response
in either gene (data not show). In contrast, the subchronic
exposures to FP and UFP induced the up-regulation of
Acta1 and Col3a1 (Fig. 7a and b).
Our results indicate that PM is not able to acutely up-
regulate these genes, but they are increased by subchronic
exposure. The presence of these two markers in various rat
cardiac disease models has been described, i.e., hypertension
or induced cardiac infarction [54]. FP and UFP have been
associated predominantly with the enhancement of the de-
velopment of cardiovascular diseases. Our results confirm
that particulate less than 2.5 μm are able to up-regulate gene
reprogramming in the heart, possibly by through an increase
in blood pressure.
There is substantial evidence to support the concept that
RAAS induces heart gene reprogramming [54–57]. For this
reason, we evaluated AT1R total protein levels in samples
from the subchronic exposure where we observed heart
gene reprogramming. We also observed an increase in the
levels of AT1R in the total protein that seems PM size-
dependent, where the highest increase was observed for
UFP followed by FP and to a lower degree for CP (Fig. 7c).
A B
Fig. 6 Acute and subchronic exposures to fine and ultrafine PM up-regulate heart AT1R mRNA. The animals were acutely (5 h/day, 3 days) or subchronically
(5 h/day, 4 days/week, 8 weeks) exposed to coarse (CP), fine (FP) and ultrafine particulate (UFP) or to filtered air (FA). Semi-quantitative levels of Angiotensin
Receptor type-1 (At1r) mRNA after a) acute and b) subchronic exposures in the heart. Scatter dot plot shows the value of the median. * indicates significant
differences among groups (n= 4 per group, p<0.05)
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Fig. 7 Subchronic exposure to fine and ultrafine PM induces heart reprogramming and up-regulates AT1R and IL-6. The animals were subchronically
exposed (5 h/day, 4 days/week for 8 weeks) to coarse (CP), fine (FP) and ultrafine particulate (UFP) or to filtered air (FA). a) Semi-quantitative levels of
alpha-skeletal actin (Acta1a) mRNA and b) Semi-quantitative levels of collagen-III (Col3a1) mRNA in the heart. Protein levels of AT1R and interleukin-6
(IL-6) are expressed in arbitrary units (AU), c) and d), respectively. Scatter dot plot shows the value of the median. * indicates significant differences
among groups (n = 4 per group, p < 0.05)
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the endothelium; also Ang-II through AT1R induces the
expression of cardiotrophin-1, leukemia inhibitory factor
and IL-6, all which are members of IL-6 family. In rodent
cardiac fibroblast these cytokines induce cardiomyocyte
hypertrophy through the activation of gp130, which is a
IL-6 receptor [58]. In this sense, we evaluated IL-6 pro-
tein levels, as a marker of inflammation response, in the
heart and observed an increment in IL-6 that could be
size-dependent where FP and UFP showed statistical sig-
nificant differences (Fig. 7d) and they have the same ten-
dency as the AT1R in the heart. Our findings suggest that
IL-6 and AT1R are induced in heart by PM exposure and
is possibly size particulate-dependent; also, IL-6 and
AT1R show the same behavior as cardiac reprogramming
genes induced by FP and UFP.
Histology of intramyocardial coronary arteries
One effect of RAAS in the heart tissue is hypertrophy and





Fig. 8 Subchronic PM exposure increases intramyocardial coronary artery w
of 5 μm myocardial slices. a) Representative slides of the hearts from rats e
particulates for 5 h/day, 4 days/week for 8 weeks. b) Box plot of ten rando
c) Semi-quantitative analysis of the presence of mononuclear cells in heart
lumen; A: Tunica adventitia; I-M: Tunica intima-media. Yellow arrows indica
dot plot shows the value of the median. * indicates significant differencesvessels. We evaluated the thickness of the intramyocardial
coronary arteries (we considered only arteries found
within the myocardium wall, but not in the epicardium or
endocardium) as a morphological effect in myocardial tis-
sue induced from the particle exposure and found that the
exposure to the three particle fractions increased the
intramyocardial coronary artery wall thickness (Fig. 8a
and c). This result is consistent with the induction of
AT1R with the three fractions and suggests the activation
of RAAS.
It has been proposed that particulate less than 2.5 μm
can pass through the lung respiratory and vascular walls
and reach the heart through the pulmonary circulation
[48, 59]. A particular observation in this study was the
presence of mononuclear cells, which seem to be macro-
phages as they display fried egg-like morphology, next to
the arteries in the heart from the UFP group and to a
minor degree from the FP group (Fig. 8c). This observa-
tion suggests an immune cellular response at the end of




























all thickness independently of PM size. Hematoxylin & Eosin staining
xposed to Filtered Air (FA), coarse (CP), fine (FP) and ultrafine (UFP)
m measurements of each coronary artery wall measured in the tissues.
coronary arteries in the groups exposed to FP and UFP. L: Artery
te mononuclear cells and blue arrows indicate a blood vessel. Scatter
among groups (n = 4 per group, p < 0.05)
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Finally, one of the most important responses to particulate
exposure is the antioxidant defense. We evaluated the
protein levels of γ-glutamyl-cysteine-synthetase catalytic
subunit (γGCSc), and heme oxygenase type-1 (HO-1) in
the lungs and heart after subchronic exposure to airborne
PM. We did not observe significant changes in γGCSc
protein levels in either tissue (data not shown). However,
the lung levels of HO-1 seem to decrease in a particulate
size-dependent manner, where the greatest down-regulation
was observed in the UFP group (Fig. 9a). The same tendency
was observed for the heart levels of HO-1, but only the ef-
fects of UFP were statistically significant (Fig. 9b).
We did not observe differences in γGCSc protein
levels in lungs and heart even though glutathione is one
of the first antioxidant defenses against oxidative stress.
Also, although γGCSc is involved in the de novo synthe-
sis of glutathione the toxic effect of PM may be directly
modifying the reduced and oxidized glutathione ratio
and diminish total glutathione levels, as it has been
reported for different progressive lung diseases [60].
Also, other antioxidant response elements such as as-
corbic acid, which is abundant in the rat lung, or HO-1
and bilirubin in the cardiovascular system, could be in-
volved in the response against PM-induced oxidative
toxicity [61].
HO-1 is an inducible stress protein enzyme that has
major role in cytoprotective defense against apoptosis, in-
flammation and oxidative stress through the catabolism of
the heme moiety and the release of Fe2+, biliverdin and
CO. The latter two metabolites are implicated in the anti-
oxidant response and vascular tone, respectively [62–64].
Low HO-1 levels have also been shown to be associated
with an impairment of the cardiovascular system [65] and
the development of lung diseases [66]. In addition, HO-1HO-1
Actin
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Fig. 9 Particle size-dependent decreases in heme oxygenase-1 after subchronic
(CP), fine (FP) and ultrafine particulate (UFP) or to filtered air as a control (FA) for 8
in arbitrary units (AU) in lungs a) and heart b). Scatter dot plot shows the value o
group, p< 0.05)levels can be down-regulated at the mRNA and protein
levels by angiotensin-II through AT1R in rat vascular
smooth muscle cells [67]. Evidence from in vitro models
(RAW 264.7, THP-1, BEAS-2B and A549 cells) exposed
to PM indicated that the induction of HO-1 depended on
the PAH content of the PM [68–70]. However, exposure
of A549 cells to 9,10-phenanthraquinone down-regulated
the expression of HO-1 [71]. Acute in vivo studies demon-
strate increases in HO-1 protein and mRNA. Neverthe-
less, in older current smokers, HO-1 mRNA is down-
regulated [72]. Furthermore, it has been observed in hu-
man populations that a larger size of the dinucleotide re-
peat polymorphism (GT) n in the HO-1 gene confers a
low induction of mRNA by tobacco smoke and is related
to the development of emphysema [73]. The same poly-
morphism has been associated with a low induction and
the development of coronary artery disease [74]. More-
over, oxidative stress during the subchronic exposure to
PM is likely to be neutralized by non-enzymatic antioxi-
dants derived from enzymatic antioxidant elements, such
as heme-metabolism/HO-1/bilirubin-biliverdin biochem-
ical route, these products, bilirubin and biliverdin, play the
main antioxidant role, thus the induction of HO-1 is prob-
ably not the primarily antioxidant biomarker in response
to the subchronic exposure.
General overview
PM pollution contributes to the development of cardio-
vascular diseases. Our results indicate that in addition to
inflammation and oxidative stress, exposure to PM in-
duces an endocrine response through the expression of
some RAAS and KKS elements. This effect could be
dependent on the particle size, the tissue type and the






















exposure in the lungs and heart. Animals were exposed subchronic to coarse
weeks (5 h/day, 4 days/week). Protein levels of heme oxygenase-1 (HO-1)
f the median. * indicates significant differences among groups (n= 4 per
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the induction of the Klk-1 in the lungs and heart of the
groups exposed to FP and UFP. Expression of Klk-1 leads
to the generation of kinin peptides through the breakdown
of KNG in tissues. However, this enzyme also can have
other substrates such as pro-renin, pro-insulin, LDL, the
precursor of atrial natriuretic factor, pro-collagenase, vaso-
active intestinal peptide and ANG. Despite the many sub-
strates of KLK-1, it has been reported that KLK-1 improves
cardiac physiology reducing blood pressure, prevents the
increment in heart mass, reduces the septal thickness and
cardiomyocyte size in hypertrophic animal models after
aortic constriction. Also, in these animals KLK-1 contrib-
utes to decrease the NADPH oxidase activity and increases
NO production through B2R [75]. Moreover, klk-1 null
mice do not show alteration in blood pressure but exhibited
abnormal structures (thin wall and diminished mass of the
left ventricle) and functions (reduced cardiac output, stroke
volume and left ventricular fractional shortening) of the
heart [76].
The above evidence indicates the importance of KLK-1
in the physiology of the cardiovascular system, in addition,
kallikrein family genes have been proposed as emerging
new markers for the development of cancer [77], and have
been weakly associated with the development of lung dis-
eases. It has been demonstrated that KLK-1 is abundant in
the lung lavage from asthmatic patients challenged with
allergen [78], as well as in an allergic sheep model. Fur-
thermore, a monoclonal antibody to KLK1 inhibited
allergen-induced late-phase bronchoconstriction and air-
way hyper-responsiveness to carbachol. Additionally, in
human tracheobronchial epithelial cells, this antibody
blocked oxidative stress-induced epidermal growth factor
receptor activation and mucus hypersecretion [79].
This evidence suggests that in the lung KLK-1 seems to
be involved in the triggering of local inflammatory response,
through breakage of KNG zymogen to bradykinin and kalli-
din by KLK-1. Bradykinin and kallidin are further broken by
the membrane-bound carboxypeptidase-M into des-Arg-
bradykinin and des-Arg-kallidin peptides, which activates
B1R that is an important inflammatory mediator [8].
For these reasons, the induction of Klk1 by FP and UFP
suggests that the generation of kinin peptides or other
substrates of KLK1 could be modified by the PM-induced
activation.
The bradykinin receptors did not show a response in
the lungs at any time of exposure. However, in the heart,
the expression of B1r increased after the acute exposure
in the three PM-exposed groups. B1r can be induced by
inflammatory cytokines, and it can regulate the induction
of iNOS enzyme. Thus, our results indicate that the three
fractions of particulate could induce the release of second-
ary mediators from the lungs to the heart, where they
were able to induce B1r.With respect to RAAS, we observed that At2r did not
change significantly at any exposure times in the lungs.
In the heart, we only observed a decrease in the mRNA
for this receptor after the subchronic exposure to UFP.
The lack of response of At2r indicates that PM mainly
promotes At1r expression more than the other mRNAs.
Ace is of particular interest because it can be a target
of PM toxicity due to having a zinc prosthetic group that
could be replaced by other divalent cations. Further-
more, this enzyme can activate angiotensin and degrade
bradykinin. We observed that the ACE mRNA and pro-
tein in the lungs were regulated mainly by CP, and not
by FP and UFP, most likely because CP can only reach
the bronchial branches and does not penetrate the lungs
as deeply as FP and UFP. Future studies should be con-
ducted to determine whether ACE protein is degraded
or is released from the lungs to the blood stream after
acute exposure to PM. This is important given that new
evidence indicates a novel pathway in which activated
ACE can be released from the cell membrane [80–83].
The principal finding of our work was that PM regulates
AT1R after acute and subchronic exposure. Although CP
did not induce the mRNA for AT1R, it was able to increase
the protein levels of this receptor as observed using the
binding assay and Western blotting. The potential mechan-
ism for the increase in AT1R protein without the mRNA
up-regulation in the CP group, it could be explained as re-
ported by Mori et al. [84], cis-acting sequences in the AT1R
gene and the glucocorticoid-responsiveness elements con-
trol the transduction process, however, AUG codon in the
5’-leader of AT1R transcripts play a role in the translation
regulation of AT1R protein, future research is necessary to
confirm this hypothesis. These results confirmed that CP
may contribute in the development or promotion of lung
and heart diseases, through the increase of Ang-II binding
and the regulation of ACE.
With respect to FP and UFP, we know that the UFP frac-
tion is included within the FP fraction. For some parame-
ters that we evaluated, such as mRNA and protein levels,
both fractions induced the same degree of response in the
lungs. However, we were able to distinguish different re-
sponses between the fractions in the heart expression of
Acta1, HO-1 and AT1R proteins. Thus, differences between
FP and UFP can be attributed to the different composition
and the deposition sites in the respiratory tract reached by
these two different particulate types.
Particle chemical composition has an important role in
particle-induced toxicity because it can promote oxidative
stress through chemical catalysis or metabolism and can
enhance inflammatory responses. Previously, the chemical
composition of PM10 and PM2.5, including the metal and
organic partial composition was reported by Guerra et al.
[85]. The total metal mass concentrations of the CP and
FP were 5488.89 and 2992.11 ng/m3, respectively. We
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from the total metal mass of CP and FP based on the re-
sults from Guerra et al. [85] (Table 3). For ten metals (Fe,
Zn, Pb, Mn, Cr, Cu, Ni, V, Co and Cd), we found that the
element with greatest mass contribution to CP and FP
was Fe, at 38.5 and 48.4 %, respectively. The second most
abundant element contributing to the CP and FP masses
was Zn, at 37.9 and 12.1 %, respectively. The rest of the
metals had a minor contributions to particle mass (less
than 12 %), but some elements are more abundant in FP
than CP. For example we found more Cd in FP than CP
(44.6 times), followed by Co (6.7 times); V (5.1 times); Cu
(2.6 times); Mn (2.2 times) and Pb (1.2 times). Biologically
relevant effects of the particle composition on RAAS were
reported by Li et al. [42], who demonstrated that particle
constituents such as V and Cu induce pulmonary artery
vasoconstriction through AT1R and ACE. According to
the authors, other metals including Ni, Fe, Mn, Zn and Al
produced a weak or no effect on vasoconstriction. Based
on the percent contribution to the mass, Zn was one of
the most abundant. It was shown that Zn contained in
PM inhibits total cardiac aconitase activity, induces mito-
chondrial DNA damage, and causes modest changes in
the cardiac expression of mRNAs involved in signaling,
ion channel function, oxidative stress, mitochondrial fatty
acid metabolism and cell cycle regulation [86].
On the basis of the information presented above and
considering the metal composition of the PM in our
study, we suggest that the biological effects observed
could be related to the presence of divalent metals that
are able to mimic prosthetic groups, such as Zn in the
ACE enzyme, or mediate oxidative stress and promote
inflammation and thus up-regulate AT1R. Although CP
and FP share some components, we suggest that the bio-
logical effect attributed to PM-associated metal content
is related to the sites in the lungs reached by the particu-
late and their potential to translocate beyond the lungs.Table 3 Metal mass contribution in coarse (CP) and fine PM
(FP) from subchronic exposure










Ni 1.7 0.7In this study it was not possible to assess UFP mass
and collect it for chemical determination. However, evi-
dence in the literature [87–89] allows to propose the
participation of divalent metals (i.e., Zn, Cu, Cd, etc.) as
the UFP-chemical components mostly involved in the
induction of the effect on RAAS and KKS. Moreover, we
do not discard that some other components (i.e., endo-
toxin and possibly other metals) may also contribute to
induce this effect as a secondary response of the release
of inflammatory mediators.
While particle composition and possibly oxidative stress
could explain the expression of AT1R, the second most
important mechanism of toxicity from the exposure to
PM is the inflammatory process. Two cytokines associated
with AT1R expression are the pleiotropic cytokine IL-6
[24, 90] and growth factor TGF-β [91, 92], both of which
are also involved in the pathological states of lung and
heart disease. We evaluated IL-6 levels as an inflammation
marker as well as an AT1R inductor. We observed that an
inflammation response was present in our experimental
model in the lungs and heart. These data suggest that IL-6
may participate in the regulation of AT1R in the acute
phase of the PM exposure but not in the subchronic ex-
posure in the lung. We suggest that in the subchronic ex-
posure the RAAS by itself maintains the induction of
AT1R, or inflammatory and/or oxidative stress responses
in the lungs may also be involved. On the other hand,
heart IL-6 levels in the subchronic exposure seem to in-
crement in a size-dependent manner as well as we ob-
served in the heart AT1R protein. However, future studies
should focus to establish whether IL-6 is determinant in
the induction of AT1R in the heart since it has been re-
ported that cytokines such as TNFα [23] and IL-1α [25]
are involved in the induction of AT1R in rat cardiac fibro-
blast and smooth muscle cells, respectively.
It is important to highlight that the differences in the PM
concentration achieved in the chambers could directly in-
fluence the biological responses observed in the present
study. The chamber PM concentrations were ~32 μg/m3
for CP, ~178 μg/m3 for FP, and ~107 μg/m3 for UFP. These
concentrations suggest the possibility that the highest bio-
logical responses should be observed in PM concentration-
response relationship, nevertheless, our data seems to indi-
cate that the molecular targets (e.g., AT1R, HO-1 etc.)
respond in a particulate size-dependent manner. However,
some biological responses were independent of the concen-
tration or the particle size such as the B1r expression in
heart in the acute exposure, lung IL-6 levels or the intra-
myocardial thickness, and could be influenced by PM
composition, yet this hypothesis needs to be confirmed.
Moreover, we have to consider that our results, based in
our experimental design, have uncertainty from other fac-
tors that include the detailed PM chemical content, the
retained dose and the intrinsic biological background.
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independent ligand-activation since it has been reported
that AT1R can function as a mechanoreceptor that
under mechanical stretch in vitro may induce RAAS ele-
ments [93, 94], and probably the physical interaction of
PM with AT1R in the cellular membrane may influence
the activation of AT1R pathway.
Finally, our results demonstrate that the three frac-
tions of PM were able to modulate their effects through
the deregulation of two endocrine systems involved in
pulmonary and cardiovascular pathology. These effects
could result from the development of the inflammation
and oxidative stress processes feeding back on the re-
sponse of the RAAS.
In this sense our results suggest that the cardiac effect
of PM is consequent to a neuro-endocrine stimulation,
which includes RAAS and KKS response, probably by
mediating vascular tone dysfunction (i.e., hypertension)
in the lung as well as in the heart. The augmented AT1R
expression observed in this study in the lungs and heart
may be related with both processes.
Conclusion
Exposure to PM is detrimental to human health. Oxida-
tive stress and inflammation are the major mechanisms
that contribute to the impairment of the lung and car-
diovascular systems. Furthermore, in the present study
we observed that PM induces the expression of the
endocrine system RAAS and KKS elements in a time-
and probably in a particulate size-dependent manner.
PM primarily promotes the expression of AT1R in the
lungs and heart, which appears to be involved in the de-
pletion of the antioxidant HO-1, as well as the tissue re-
modeling and heart gene reprogramming resulting from
a subchronic exposure to FP and UFP, concomitantly,
PM induces acute IL-6 response in the lung and sub-
chronic response in the heart. Thus, these findings con-
tribute to the understanding of the underlying
mechanisms involved in the development of cardiac dis-
ease associated with PM exposure.
Methods
Inhalation exposure
The present study was carried out in the north of Mexico
City, an area with high traffic affluence and industrial ac-
tivity [95], during the months of May to July, 2009. The
particulate concentrator was localized within the Animal
Care Unit at CINVESTAV-IPN.
Male Sprague Dawley rats (purchased from Harlan,
Mexico; 4 rats/group) were exposed acutely (3 days, 5 h
per day) and subchronically (8 weeks, 4 days/week, 5 h
per day) to coarse (CP), fine (FP), or ultrafine (UFP) par-
ticulate using an aerosol enrichment concentrator system.
A control group was exposed to filtered air (FA). The FPfraction was defined as particulate less than or equal to
2.5 μm, which includes the UFP fraction. The particulate
concentration in the exposure chambers was 32, 178 and
107 μg/m3 for CP, FP, and UFP, respectively. Simultaneous
air ambient concentration of PM10 and PM2.5 were moni-
tored and those results were accompanied with the partial
chemical composition of PM10 and PM2.5 in the study de-
veloped and reported by Guerra-García et al. [85].
At the end of the each exposure (24 h after the last ex-
posure), the animals were anesthetized (i.p. 10-20 mg/kg
of sodium pentobarbital) and euthanized by exsanguin-
ation. The lung and heart tissues were dissected and fro-
zen in liquid nitrogen and stored at -70 °C until analysis.
A ventricular slice of the heart was fixed in 10 % buff-
ered formaldehyde and embedded in paraffin for histo-
logical analysis.
Semi-quantitative reverse transcription-polymerase chain
reaction
Total RNA was isolated from the lungs and heart using
TRIzol reagent (Invitrogen™, Life Technologies, Thermo
Fisher Scientific, Carlsbad, CA, USA). cDNA synthesis was
performed with 3 μg of total RNA according to the manu-
facturer’s instructions (SuperScript II, Invitrogen™, Life
Technologies, Thermo Fisher Scientific, Carlsbad, CA,
USA). Specific oligonucleotides were designed for each
gene (Table 4) using GeneRunner software, and we con-
firmed their amplification using Primer-BLAST [http://
www.ncbi.nlm.nih.gov/tools/primer-blast/]. We chose three
RAAS genes (At1r, At2r and Ace) and three KKS genes
(B1r, B2r and Klk-1) on the basis of their roles as the effec-
tors and mediators of the metabolism of the active peptides.
To evaluate heart gene reprogramming, we evaluated the
mRNA levels of Acta1 and Col3a1. We used 18S and
Gapdh as housekeeping genes. After PCR amplification, the
PCR products were loaded and subjected to electrophoresis
in 1.5 % agarose gels, stained with ethidium bromide and
photodocumented in a transilluminator (UVP EC3 imaging
system, UVP Inc., Upland, CA, USA). Densitometry was
performed with the software Image J (National Institutes of
Health, USA).
Western blot
To obtain the total protein, the lung samples were homoge-
nized with Nonidet-P40 buffer (150 mM NaCl, 1 % NP40,
50 mM Tris–HCl, pH 8.0, and protease inhibitors) and cen-
trifuged at 10,000 rpm 4 °C. The supernatant was collected
and stored at -70 °C until use.
Nuclear and non-nuclear cell fractions were obtained
following the Abcam protocol. Briefly, the tissue was ho-
mogenized with cytoplasmic buffer (250 mM sucrose,
20 mM HEPES pH 7.4, 10 mM KCl, 1.5 mM MgCl2,
1 mM EDTA, 1 mM EGTA, 1 mM DTT). The homogen-
ate was centrifuged at 3000 rpm for 5 min, and the
Table 4 Oligonucleotides used for PCR amplification. The gene name, the sequence of forward (Fw) and reverse (Rv) oligonucleotide,
the PCR product and the Genbank ID are shown
Gen Olinucleotides PCR product (pb) Genbank ID
At1r Fw 5'-AATATTTGGAAACAGCTTGGT-3' 331 [GenBank: NM_030985]
Rv 5'-ATGATGATGCAGGTGACTTTG-3'
At2r Fw 5'-TAGTTCCCCTTGTTTGGTG-3' 428 [GenBank: NM_012494]
Rv 5'-GAGGATGGCAAAAGGAAGT-3'
Ace Fw 5'-CCAACAAGACTGCCACCTG-3' 457 [GenBank: NM_012544]
Rv 5'-GTACTGGTGACATCGAGGTTG-3'
B1r Fw 5'-AGCATCTTCCTGGTGGTGG-3' 420 [GenBank: NM_030851]
Rv 5'-CCAGCAGACCAGGAAGGAG-3'
B2r Fw 5'-GAGATCTACCTGGGCAACCT-3' 599 [GenBank: NM_173100]
Rv 5'-AGGAAGGTGCTGATCTGGAA-3'
Klk-1 Fw 5'-CCCTCACCCTGACTTCAAC-3' 236 [GenBank: 001005382]
Rv 5'-TCACACACTGGAGCTCATC-3'
Acta1 Fw 5'-ACATCGACATCAGGAAGGAC-3' 234 [GenBank: NM_019212]
Rv 5'-CGTCGTACTCCTGCTTGGT-3'
Col3a1 Fw 5'-AGGGTGATCGTGGTGAAAA-3' 239 [GenBank: NM_032085]
Rv 5'-TCCTCGATGTCCTTTGATG-3'
18S Fw 5'-GCAGCTAGGAATAATGGAATA-3' 188 [GenBank: NR_046237]
Rv 5'-GACTTTCGTTCTTGATTAATGA-3'
Gapdh Fw 5'-ACCACAGTCCATGCCATCAC-3' 166 [GenBank: NM_017008]
Rv 5'-TGCCAGTGAGCTTCCCGTT-3'
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clear pellet was dispersed with a pipette, and then the first
step was repeated to remove cytosolic contaminants from
the pellet. The nuclear pellet was resuspended in the nu-
clear buffer (cytoplasmic buffer with 10 % glycerol and
0.1 % SDS). Finally, the nuclear pellet was sonicated on ice
and centrifuged at 10,000 rpm, and the supernatant was
removed and stored at -70 °C. The protein concentrations
were determined using Bradford protein assay. A 6×
Laemmli buffer was added to 30 μg of protein, and the
sample was loaded in 12 % SDS-polyacrylamide gel and
transferred to a PVDF membrane.
The membranes were blocked for 1 h with 5 % of not-
fat milk. The membranes were then incubated overnight
with primary antibodies to AT1R (1:600, rabbit poly-
clonal AT1 306 antibody, Sc-579), ACE (1:1000; goat
polyclonal ACE N-20 antibody, Sc-12184), HO-1 (1:500,
rabbit polyclonal HO-1 H-105 antibody, Sc-10789) and
γ-GCSc (1:600, rabbit polyclonal γ-GCSc H-338 anti-
body, Sc-22755) all from Santa Cruz Biotechnology
(Delaware Ave, Santa Cruz, CA, USA). HRP-conjugated
secondary antibodies (Bio-Rad laboratories, Hercules, CA,
USA) were incubated 1 h at a dilution of 1:10,000. Immu-
noreactivity was detected using ECL western blotting detec-
tion reagents (GE health care, Buckinghamshire HP7 9NA,
UK). The bands were visualized by exposure to x-ray film.The x-ray film was photodocumented with a UVP (UVP
EC3 imaging system, UVP Inc., USA). We used α-actin
(donated by Dr. Hernández- Hernández, CINVESTAV-
IPN) as an internal control to correct for protein loading.
For the subcellular fractions, we used GAPDH (1:1000,
mouse monoclonal GAPDH 6C5 antibody, Sc-32,233) and
acetyl-Histone-4 (1:1000, mouse monoclonal Ac-Histone
H4 Ser 1/Lys 5/Lys 8/Lys 12 antibody, Sc-34,263) to con-
firm the purity of the fractions.
[3H]-Angiotensin-II binding to lung cell membranes
The lung tissue samples were placed in 10 ml of lysis buf-
fer (10 mM Tris–HCl, 1 mM EGTA, pH 7.4 at 4 °C) and
homogenized with a Polytron (3 cycles, 5 s each). The
homogenate was centrifuged (1,000×g, 10 min, 4 °C), the
pellet was discarded and the supernatant was centrifuged
at 42,000×g (20 min, 4 °C). The resulting pellet was resus-
pended in lysis buffer and centrifuged again (42,000 × g,
20 min, 4 °C). The pellet (membranes) was resuspended in
incubation buffer (20 mM Tris–HCl, 5 mM MgCl2,
100 mM NaCl, 2 mg/ml bovine serum albumin (BSA);
pH 7.4 at 4 °C), and the suspension was immediately used
in binding assays. The protein contents were determined
by the Bradford assay, using BSA as standard.
Saturation analysis was carried out in 100 μl of incuba-
tion buffer containing [Tyrosil-3,5-3H (N)]-Angiotensin-II
Aztatzi-Aguilar et al. Particle and Fibre Toxicology  (2015) 12:17 Page 16 of 18(ARC inc., Saint Louis, MO, USA) (0.5-40 nM) and ~40 μg
protein. For single-point experiments, the incubations
contained 10 nM [3H]-Angiotensin-II. The samples were
equilibrated for 60 min at 25 °C in a water bath with
continuous gentle rocking, and the incubations were termi-
nated by filtration through Whatman GF/B glass fiber
paper, pre-soaked in 0.3 % polyethylenimine. Non-specific
binding was determined as the binding insensitive to
100 μM of the antagonist telmisartan (Sigma Aldrich,
USA). The filters were washed 3 times with 1 ml ice-cold
Tris–HCl buffer (20 mM, pH 7.4), soaked in 3 ml scintilla-
tor, and the tritium content was determined by liquid scin-
tillation spectroscopy (Multi-purpose Scintillation Counter,
Beckman LS-6500). The saturation binding data were fit
with a hyperbolic function using non-linear regression with
GraphPad Prism 5 (Graph Pad Software, San Diego, CA,
USA).
Histology
Slides of 5 μm sections of the heart tissues were stained
with Hematoxylin/Eosin stain. We photographed all of the
intramyocardial coronary arteries observed in the slides
(two slides from each tissue sample). We performed a
blinded analysis of the measure of the thickness using
Image J. Twenty radial measurements for each artery from
the intima to the adventitia wall were registered. For the
statistical analysis we used the median of each artery; we
included in the analysis between 15 to 25 arteries per
group. Semi-quantitative analysis of mononuclear cells in
heart tissue was performed counting the number of fields
with mononuclear cells per slide.
Statistical analysis
All statistical analyses were performed using SigmaPlot
version 11.0. We performed descriptive statistical analyses.
To compare the four groups, we performed Kruskal-
Wallis test, considering non-normal data distribution.
Student Newman-Keul’s post-hoc test was used for all
pair-wise comparisons. We considered the differences to
be statistically significant when P ≤ 0.05. All comparisons
were performed with respect to filtered air as the control
group.
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